Press Releases and Events

PRESS RELEASES

Press Release | December 9, 2024

Crinetics Announces FDA Acceptance of New Drug Application for Paltusotine for Adult Patients with Acromegaly

READ MORE
Press Release | November 15, 2024

Crinetics Pharmaceuticals to Participate in Three Upcoming December Investor Conferences

READ MORE
Press Release | November 12, 2024

Crinetics Pharmaceuticals to Showcase Pipeline Advancements with Neuroendocrine Tumor Candidates at The North American Neuroendocrine Tumor Society (NANETS) Annual Meeting

READ MORE
Press Release | November 12, 2024

Crinetics Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update

READ MORE
Press Release | November 11, 2024

Crinetics Announces November 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

READ MORE
Press Release | October 10, 2024

Crinetics Announces October 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

READ MORE
Press Release | October 8, 2024

Crinetics Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock

READ MORE
Press Release | October 8, 2024

Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock

READ MORE
Press Release | September 26, 2024

Crinetics Submits New Drug Application for Paltusotine for the Treatment of Acromegaly

READ MORE
Press Release | September 10, 2024

Crinetics Announces September 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

READ MORE
6 / 24